Canadian National Railway Company’s Superior Proposal for $33.7 Billion Combination with Kansas City Southern
April 21, 2021
On April 20, 2021, Canadian National Railway Company (“CN”) announced that it has made a superior proposal to combine with Kansas City Southern (“KCS”) in a cash‑and‑stock transaction valued at $33.7 billion, or $325 per share. Together, CN and KCS will create a premier railway for the 21st century by connecting ports and rails in the United States, Mexico and Canada and providing superior service, enhanced competition and new market access to move goods across North America efficiently and safely. Cravath is representing CN in connection with the transaction.
The Cravath team is led by partner Robert I. Townsend III and includes associates Eric S. Goodwin and Jerome C. Newton on M&A matters; partners Craig F. Arcella and Stephen M. Kessing, senior attorney Sarah F. Rosen and associates D. Ana Choi and Caroline H. Gieryn on financing matters; partner Lauren Angelilli and associate Richard Bohm on tax matters; partners Jonathan J. Katz and Matthew J. Bobby and associate Anna Mikaelyan on executive compensation and benefits matters; and partner Christine A. Varney and associate Kolja I. Ortmann on regulatory matters. Evan S. Gabor also worked on M&A matters and Alissa B. Fromkin worked on tax matters.
Related Practices & Industries
People
- Photo
-
-
J.D., 1990, Harvard Law Schoolmagna cum laude
-
A.B., 1987, Harvard Collegemagna cum laude
- New York
Education
Admitted In
- Photo
-
-
J.D., 1998, Columbia Law SchoolHarlan Fiske Stone Scholar
-
B.A., 1995, Duke University
- New York
Education
Admitted In
- Photo
-
-
J.D., 2005, Duke Law SchoolOrder of the Coif, magna cum laude
-
M.B.A., 2001, University of Southern California
-
B.S., 1995, Miami University of Ohio
- New York
Education
Admitted In
-
J.D., 2005, Columbia Law SchoolHarlan Fiske Stone Scholar
-
B.A., 2002, New York Universitymagna cum laude
- New York
Education
Admitted In
-
J.D., 2000, Harvard Law Schoolcum laude
-
B.S., 1996, The Wharton School of the University of Pennsylvaniamagna cum laude
- New York
Education
Admitted In
- Photo
-
-
LL.M., 2013, New York University School of Law
-
J.D., 2007, Benjamin N. Cardozo School of LawOrder of the Coif, Dean's Distinguished Scholar, summa cum laude
-
B.S., 2003, Cornell University
- New York
Education
Admitted In
- Photo
-
-
J.D., 2012, Harvard Law Schoolmagna cum laude
-
M.A., 2009, University of Pennsylvania
-
B.A., 2009, University of PennsylvaniaPhi Beta Kappa, summa cum laude
- New York
Education
Admitted In
- Photo
-
-
J.D., 1986, Georgetown University Law Center
-
M.P.A., 1982, Syracuse University
-
B.A., 1977, State University of New York, Albany
- New York
- District of Columbia
Education
Admitted In
Related News & Insights
Deals & Cases
April 19, 2021
Aras’s Significant Growth Investment by GI Partners
On April 19, 2021, Aras, the only resilient platform provider for digital industrial applications with open, low code technology, announced a substantial growth investment from GI Partners, a leading private investment firm. Cravath is representing Aras in connection with the transaction.
Deals & Cases
April 16, 2021
IBM’s Acquisition of myInvenio
On April 15, 2021, IBM announced a definitive agreement to acquire myInvenio, a process mining software company based in Reggio Emilia, Italy. The acquisition will provide organizations with data‑driven software to help them identify the most impactful business processes to automate using AI – including sales, procurement, production and accounting. Financial details were not disclosed. Cravath is representing IBM in connection with the transaction.
Deals & Cases
April 15, 2021
Thermo Fisher Scientific’s $20.9 Billion Acquisition of PPD, Inc.
On April 15, 2021, Thermo Fisher Scientific Inc. (“Thermo Fisher”), a leader in serving science, and PPD, Inc. (“PPD”), a leading provider of clinical research services to the pharma and biotech industry, announced that their boards of directors have approved a definitive agreement under which Thermo Fisher will acquire PPD for $47.50 per share for a total cash purchase price of $17.4 billion plus the assumption of approximately $3.5 billion of net debt. Cravath is representing Thermo Fisher in connection with the transaction.
Deals & Cases
April 12, 2021
DiaSorin’s $1.8 Billion Acquisition of Luminex Corporation
On April 11, 2021, DiaSorin S.p.A. (“DiaSorin”), a leading global diagnostics company, announced that its Board of Directors has unanimously approved and signed a definitive merger agreement for DiaSorin to acquire Luminex Corporation (“Luminex”), a leader in multiplexing technology, for a price of $37.00 per share in an all‑cash transaction corresponding to an enterprise value of approximately $1.8 billion. Cravath is representing DiaSorin in connection with the transaction.
